These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 18457327)

  • 21. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
    Martín A; Conde E; Arnan M; Canales MA; Deben G; Sancho JM; Andreu R; Salar A; García-Sanchez P; Vázquez L; Nistal S; Requena MJ; Donato EM; González JA; León A; Ruiz C; Grande C; González-Barca E; Caballero MD;
    Haematologica; 2008 Dec; 93(12):1829-36. PubMed ID: 18945747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi.
    Israëls T; van de Wetering MD; Hesseling P; van Geloven N; Caron HN; Molyneux EM
    Pediatr Blood Cancer; 2009 Jul; 53(1):47-52. PubMed ID: 19338050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.
    Rizzieri DA; Johnson JL; Niedzwiecki D; Lee EJ; Vardiman JW; Powell BL; Barcos M; Bloomfield CD; Schiffer CA; Peterson BA; Canellos GP; Larson RA
    Cancer; 2004 Apr; 100(7):1438-48. PubMed ID: 15042678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome in patients with non-hodgkin lymphoma and with or without human immunodeficiency virus infection.
    Spina M; Carbone A; Vaccher E; Gloghini A; Talamini R; Cinelli R; Martellotta F; Tirelli U
    Clin Infect Dis; 2004 Jan; 38(1):142-4. PubMed ID: 14679461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients.
    Xicoy B; Ribera JM; Müller M; García O; Hoffmann C; Oriol A; Hentrich M; Grande C; Wasmuth JC; Esteve J; van Lunzen J; Del Potro E; Knechten H; Brunet S; Mayr C; Escoda L; Schommers P; Alonso N; Vall-Llovera F; Pérez M; Morgades M; González J; Fernández A; Thoden J; Gökbuget N; Hoelzer D; Fätkenheuer G; Wyen C;
    Leuk Lymphoma; 2014 Oct; 55(10):2341-8. PubMed ID: 24397614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of the HIV-associated Burkitt lymphoma in a three-year-old child.
    Fedorova A; Mlyavaya T; Alexeichik A; Busel T; Petrovich I; Aleinikova O
    Pediatr Blood Cancer; 2006 Jul; 47(1):92-3. PubMed ID: 16047357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Achieving Bcl-2/IgH negativity in peripheral blood/bone marrow after therapy implies better prognosis for patients with follicular lymphoma].
    Belada D; Smolej L; Stepánková P; Beránek M; Dvoráková D; Bukac J; Malý J
    Vnitr Lek; 2007 Oct; 53(10):1057-63. PubMed ID: 18072430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
    Alwan F; He A; Montoto S; Kassam S; Mee M; Burns F; Edwards S; Wilson A; Tenant-Flowers M; Marcus R; Ardeshna KM; Bower M; Cwynarski K
    AIDS; 2015 May; 29(8):903-10. PubMed ID: 25730506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The specific features of renal lesion in Burkitt's lymphoma].
    Lukina AE; Bariakh EA; Kravchenko SK; Biriukova LS; Gemdzhian ÉG; Magomedova AU; Kremenetskaia AM; Vorob'ev AI
    Ter Arkh; 2012; 84(7):31-4. PubMed ID: 23038969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients.
    van 't Veer MB; de Jong D; MacKenzie M; Kluin-Nelemans HC; van Oers MH; Zijlstra J; Hagenbeek A; van Putten WL
    Br J Haematol; 2009 Feb; 144(4):524-30. PubMed ID: 19036081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.
    Choi KA; Lee JE; Kim YG; Kim DJ; Kim K; Ko YH; Oh HY; Kim WS; Huh W
    Ann Hematol; 2009 Jul; 88(7):639-45. PubMed ID: 19030857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.
    Tarella C; Zanni M; Magni M; Benedetti F; Patti C; Barbui T; Pileri A; Boccadoro M; Ciceri F; Gallamini A; Cortelazzo S; Majolino I; Mirto S; Corradini P; Passera R; Pizzolo G; Gianni AM; Rambaldi A
    J Clin Oncol; 2008 Jul; 26(19):3166-75. PubMed ID: 18490650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotypic variations of Burkitt lymphoma.
    Kelemen K; Braziel RM; Gatter K; Bakke TC; Olson S; Fan G
    Am J Clin Pathol; 2010 Jul; 134(1):127-38. PubMed ID: 20551277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post cardiac transplantation lymphoproliferative disorder presenting as t(8;14) Burkitt leukaemia/lymphoma treated with low intensity chemotherapy and rituximab.
    Windebank K; Walwyn T; Kirk R; Parry G; Hasan A; Bown N; Wilkins B
    Pediatr Blood Cancer; 2009 Sep; 53(3):392-6. PubMed ID: 19459198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.
    Billio A; Svaldi M; Morello E; Amato B; Coser P
    Am J Hematol; 2006 Oct; 81(10):798-9. PubMed ID: 16838326
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum BAFF predicts prognosis better than APRIL in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP chemotherapy.
    Kim SJ; Lee SJ; Choi IY; Park Y; Choi CW; Kim IS; Yu W; Hwang HS; Kim BS
    Eur J Haematol; 2008 Sep; 81(3):177-84. PubMed ID: 18510703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rituximab and chemotherapy in primary gastric lymphoma.
    Avilés A; Castañeda C; Cleto S; Neri N; Huerta-Guzmán J; Gonzalez M; Nambo MJ
    Cancer Biother Radiopharm; 2009 Feb; 24(1):25-8. PubMed ID: 19216628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.
    Hoffmann C; Wolf E; Wyen C; Fätkenheuer G; Van Lunzen J; Stellbrink HJ; Stoehr A; Plettenberg A; Jaeger H; Noppeney R; Hentrich M; Goekbuget N; Hoelzer D; Horst HA
    Leuk Lymphoma; 2006 Sep; 47(9):1872-80. PubMed ID: 17065000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intensive chemotherapy for Burkitt lymphoma in HIV positive patients].
    Puga L B; Bustamante K K; Molina E J; Andrade M A
    Rev Med Chil; 2015 Dec; 143(12):1505-11. PubMed ID: 26928610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.